Pharma Focus America
ThermoFisher Scientific - Go beyond the catalog

Aytu BioPharma Subleases a Portion of Its Manufacturing Facility in USA

Introduction:

Aytu BioPharma and AMT Manufacturing Solutions have recently reached an agreement regarding the subleasing of a portion of Aytu's manufacturing facility located in Grand Prairie, Texas, in the United States.

Features:

This collaborative agreement allows AMT to utilize a section of Aytu's FDA and DEA-approved pharmaceutical production plant.

The sublease encompasses an area of 22,909 square feet, which accounts for more than 30% of Aytu's existing production facility.

As part of the agreement, the sublease will be expanded to encompass the remaining manufacturing space, totaling 77,112 square feet.

The expanded sublease is expected to come into effect on April 1, 2024, and will conclude no later than December 31, 2024. During this period, AMT will have access to the additional manufacturing facility provided by Aytu.

Specifications:

Name

Aytu BioPharma

Type

Expansion

Year

2024

Sartorius Lab Balance CleaningFestival of Biologics San Diego 2024Equinix accelerated medical research...World Vaccine Congress Europe 2024World Orphan Drug Congress 2024World Vaccine Congress Washington 2024Future Labs Live USA 2024Interphex 2024Pharma USA 2024Healthcare CNO SummitHealthcare CMO Summit